Skip to main content
. 2017 Dec 11;9(5):5993–6006. doi: 10.18632/oncotarget.23202

Figure 7. Down regulation of cIAP-1, cIAP-2, XIAP, MDM2 and activation of p53.

Figure 7

AGS and SNU-484 were treated with indicated concentrations of scutellarein or 24 h. The cell lysates were subjected to SDS–PAGE and analyzed by immune-blotting. Densitometry analyses of cIAP-1,-2, XIAP, MDM2, p53 and p-p53 proteins expressions were expressed as mean ± SD of three independent experiments. (**P < 0.05 ***P < 0.01 compared to control).